Cargando…

Glutamatergic Control of Striatal Dopamine Release in Normal Rats and 6-OHDA Rats with Intrastriatal Grafts

Recent animal experiments suggest that transplanted neurons become integrated with the host brain. Neuroanatomical studies have shown that transplanted dopaminergic neurons can form synaptic connections on target cells in the host striatum. Other studies also have shown that grafted neurons not only...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kondoh, T., Low, W. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1992
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565184/ http://dx.doi.org/10.1155/NP.1992.225

Ejemplares similares

Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease
por: Boronat-García, Alejandra, et al.
Publicado: (2016)

Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression
por: Wang, Lizheng, et al.
Publicado: (2017)

Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
por: Antipova, Veronica, et al.
Publicado: (2021)

Development and Integration of Intrastriatal Striatal Grafts Implanted Into Long-Term Ibotenate Lesions
por: Labandeira-García, J. L., et al.
Publicado: (1992)

Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson's Disease in Rats
por: Soner, Burak Cem, et al.
Publicado: (2021)

Local control of striatal dopamine release
por: Cachope, Roger, et al.
Publicado: (2014)

Treadmill Exercise Improves Motor Dysfunction and Hyperactivity of the Corticostriatal Glutamatergic Pathway in Rats with 6-OHDA-Induced Parkinson's Disease
por: Chen, Wei, et al.
Publicado: (2017)

Olfactory Bulb D(2)/D(3) Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
por: Alberts, Teresa, et al.
Publicado: (2022)

Paeonol Protection Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease
por: Ghalami, Jamileh, et al.
Publicado: (2021)

Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion
por: Aceves Buendia, Jose de Jesus, et al.
Publicado: (2017)

Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B
por: Batassini, Cristiane, et al.
Publicado: (2015)

Antioxidant Effect of Alpha-Lipoic Acid in 6-Hydroxydopamine Unilateral Intrastriatal Injected Rats
por: Andreeva-Gateva, Pavlina, et al.
Publicado: (2020)

Pioglitazone enhances brain mitochondrial biogenesis and phase II detoxification capacity in neonatal rats with 6-OHDA-induced unilateral striatal lesions
por: Vázquez-González, Daniela, et al.
Publicado: (2023)

Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson’s Disease
por: Mitra, Reinika, et al.
Publicado: (2015)

Plasticity in striatal dopamine release is governed by release-independent depression and the dopamine transporter
por: Condon, Mark D., et al.
Publicado: (2019)

Dopamine Transporter Loss in 6-OHDA Parkinson’s Model Is Unmet by Parallel Reduction in Dopamine Uptake
por: Chotibut, Tanya, et al.
Publicado: (2012)

Deficits in striatal dopamine release in cannabis dependence
por: van de Giessen, Elsmarieke, et al.
Publicado: (2016)

Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity
por: Huang, Chun, et al.
Publicado: (2018)

Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone
por: Rodrigues, Laís D., et al.
Publicado: (2019)

Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease
por: Barata-Antunes, Sandra, et al.
Publicado: (2020)

Microencapsulated Dopamine (DA)-Induced Restitution of Function in 6-OHDA-Denervated Rat Striatum in vivo: Comparison Between Two Microsphere Excipients
por: McRae, Amanda, et al.
Publicado: (1991)

Treadmill Running Combined with Microdialysis to Evaluate Motor Deficits and Improvement Following Dopaminergic Grafts in 6-OHDA Lesioned Rats
por: Hattori, S., et al.
Publicado: (1992)

Striatal Dopamine Release in Schizophrenia Comorbid with Substance Dependence
por: Thompson, Judy L., et al.
Publicado: (2012)

Methamphetamine-Induced Dopamine-Independent Alterations in Striatal Gene Expression in the 6-Hydroxydopamine Hemiparkinsonian Rats
por: Cadet, Jean Lud, et al.
Publicado: (2010)

Impact of adolescent ethanol exposure and adult amphetamine self-administration on evoked striatal dopamine release in male rats
por: Granholm, L., et al.
Publicado: (2015)

The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization
por: Stocco, Marlaina R., et al.
Publicado: (2021)

Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study
por: Wąsik, Agnieszka, et al.
Publicado: (2017)

The Influence of Striatal Astrocyte Dysfunction on Locomotor Activity in Dopamine-depleted Rats
por: Voronkov, Dmitry, et al.
Publicado: (2021)

Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity
por: Lu, Di-Sheng, et al.
Publicado: (2018)

Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I, et al.
Publicado: (2015)

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
por: Collins, Louise M, et al.
Publicado: (2014)

Effect of Adenosine A(2A) Receptor Antagonists and l-DOPA on Hydroxyl Radical, Glutamate and Dopamine in the Striatum of 6-OHDA-Treated Rats
por: Gołembiowska, Krystyna, et al.
Publicado: (2011)

Sleep deprivation disrupts striatal anti-apoptotic responses in 6-hydroxy dopamine-lesioned parkinsonian rats
por: Ahmadian, Nahid, et al.
Publicado: (2018)

Salsolinol Facilitates Glutamatergic Transmission to Dopamine Neurons in the Posterior Ventral Tegmental Area of Rats
por: Xie, Guiqin, et al.
Publicado: (2012)

Levodopa Reverses Cytokine-Induced Reductions in Striatal Dopamine Release
por: Felger, Jennifer C., et al.
Publicado: (2015)

Local and global consequences of reward-evoked striatal dopamine release
por: Li, Nan, et al.
Publicado: (2020)

Modulation of striatal glutamatergic, dopaminergic and cholinergic neurotransmission pathways concomitant with motor disturbance in rats with kaolin-induced hydrocephalus
por: Chen, Li-Jin, et al.
Publicado: (2022)

Neuroglial Plasticity at Striatal Glutamatergic Synapses in Parkinson's Disease
por: Villalba, Rosa M., et al.
Publicado: (2011)

Corrigendum: Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity
por: Lu, Di-Sheng, et al.
Publicado: (2020)

Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson’s disease rat model
por: Park, Hyung Woo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_snm1kpm134p627s4r99leh8qph